Investigational Drug Services & VA Research
Download
Report
Transcript Investigational Drug Services & VA Research
Merrell Lim, Pharm.D.
Investigational Drug Services Pharmacist
[email protected]
317-944-1900
Learn about services provided by
investigational drug services (IDS)
pharmacy
Understand the role of IDS staff
Learn about importance of drug
accountability
Gain further understanding of operations
within the IDS pharmacy
IDS Pharmacy:
IDS hours
◦ Coordinate Phase I to Phase IV studies
◦ Commercially available and investigational agents
◦ Drug accountability, record keeping, study
procedures
◦ 8:00 a.m. ~ 4:30 p.m.
◦ Monday to Friday
IDS Location:
IDS Staff:
◦ IU Simon Cancer Center Room C2102
◦ Three full-time pharmacists
◦ Four pharmacy technicians
Responsibilities of IDS Pharmacists:
Responsibilities of IDS technicians:
◦
◦
◦
◦
◦
Review study protocols
Participate in ‘study start-up activities’
Write study procedures
Verify study drugs prepared by IDS technicians
Participate as reviewer for IRB Committee
◦ Drug preparation
◦ Drug procurement (ordering, returns, inventory
management)
◦ Study monitor guidance
◦ Study billing
Drug accountability involves:
◦
◦
◦
◦
◦
◦
◦
◦
◦
Drug procurement
Drug and patient specific logs
Control site VS. Satellite site
Storage
Drug packaging/Blinding
Randomization
Labeling
Drug dispensing
Drug returns
Study drugs can be obtained from:
◦ Research organization
◦ Study company
Methods
◦ Company order sheets
◦ Phone calls
◦ Interactive Voice Response System (IVRS)
Study drugs not ordered in bulk
Drug accountability logs
◦ Completed with each study drug transaction
◦ Completed at time of study drug receipt or
dispensing
Patient specific logs
Tear off labels
◦ Used in addition to the ‘Drug Accountability Logs’
◦ Affixed to specific patient log to track study drug
dispensing
IDS Pharmacy
(Control Site)
Riley
Inpatient
Pharmacy
(Satellite Site)
Eagle
Highlands
Medical Offices
(Satellite Site)
Methodist
Inpatient
Pharmacy
(Satellite Site)
IDS storage area for:
◦ Study binders
◦ Study drugs
◦ Study drug returns
Study drugs stored specific to drug product:
◦ Room temperature/Refrigerator/Freezer
◦ Light Sensitivity
Items arranged by IRB# assigned
Pharmacy blinded
◦ Study drug name/placebo
◦ Bottle/vial number
◦ IVRS needed to assign drug/placebo to patient
Pharmacy unblinded
◦ Active drug and placebo shipped separately
◦ IVRS or randomization chart needed to assign study
drug/placebo to patient
Breaking the blind
◦ Principle investigator is the only person to break
blind
◦ AVOID breaking blind if possible
◦ If treating adverse reactions, treat subject as if on
active drug
Methods of randomizing patients
◦ Randomized by research RN (at screening)
◦ Pre-printed randomization lists
◦ Sealed envelopes
◦ Interactive Voice Response System (IVRS)
IDS Pharmacy labeling
◦ Drug name
Listed as “Study drug/placebo”
◦
◦
◦
◦
◦
IRB #
Study Protocol #
Drug formulation
Quantity
Hospital name and address
Patient specific log filled out
Research RN picks up study medications
No counseling from IDS about study
medications
Returning containers
◦ Educate patients on adherence issues
Visits by study monitor
Reviewing of accountability logs
Destroying study medications on site
Returning supply to study sponsor
◦ Check and see what sponsor requires
Prepare budget for study (pharmacy portion)
Attend IRB meeting to have study approved
Build study product in Cerner
Attend start up meeting
Write study procedures
Create and build order sets
Have order sets approved
Print copies of procedures and study logs and
have technician create study binder
Document all shipping and correspondence in
file cabinet
Checking study drug product
Documenting study drug usage in
accountability logs
Accommodating monitor visits
Close out studies that are completed
Billing issues
IDS website:
www.clarian.org/investigationaldrugservices
IDS Pharmacists:
IDS Technicians:
◦ Bonnie Klank, Pharm.D. ([email protected])
◦ Edward Leung, Pharm.D. ([email protected])
◦ Merrell Lim, Pharm.D. ([email protected])
◦
◦
◦
◦
Denise Cox ([email protected])
Ronda Murphy ([email protected])
Jan Pfeiffer ([email protected])
Jada Weger-Effinger ([email protected])